You are here: Industry Insights > Pfizer

News List

Pfizer's leukaemia drug gets opposing regulatory decisions on either side of the Atlantic pharmafile
August 21, 2017
Pfizer has received a bittersweet bout of news as it emerges that its drug Besponsa (inotuzumab ozogamicin) has received approval in the US, but has been rejected in the UK.
Pfizer wins approval for blood cancer drug Besponsa fiercepharma
August 18, 2017
Pfizer has won FDA approval of a new drug to treat acute lymphoblastic leukemia.
eFFECTOR Therapeutics completes $38.6 million Series C financing biospectrumasia
August 11, 2017
Pfizer Venture Investments (PVI) led the round and was joined by additional new investors including Alexandria Venture Investments.
Pfizer’s major drug gains doubles sales but overall revenue falls pharmafile
August 02, 2017
Pfizer revealed in its briefing on its second quarter financials that Ibrance, its breast cancer treatment, had grown in sales by 66% but overall revenue was down to $12.9 billion from $13.15 billion.
Pfizer's second-quarter sales fall 2 percent, missing estimates firstwordpharma
August 02, 2017
Pfizer announced Tuesday that second-quarter sales declined 2 percent year-over-year to $12.9 billion, missing analyst expectations of $13.1 billion, partly due to lower revenue from Enbrel and Prevnar 13/Prevenar 13.
Merck, Pfizer’s avelumab clears first hurdle in early access scheme pharmatimes
July 25, 2017
Patients with Merkel Cell Carcinoma living in the UK are a step closer to getting early access to Merck and Pfizer’s avelumab after regulators assigned the drug Promising Innovative Medicines (PIM) status.
Over 3% of all drugs in Indian market not up to standard pharmafile
July 25, 2017
The Central Drugs Standard Control Organisation (CDSCO) tested drugs to determine whether they were of standard quality but found that 946 of the medicines across 66 companies failed the test.
Merck and Pfizer collaborate with Corning to modernize pharmaceutical glass packaging cphi-online
July 25, 2017
Collaborations result in development of Corning Valor Glass.
Merck and Pfizer collaborate with Corning worldpharmanews
July 21, 2017
Merck , Pfizerand Corning Incorporated today announced collaborations that have enabled the modernization of pharmaceutical packaging with the introduction of Corning Valor™ Glass
US FDA accepts Pfizer’s sNDA for Xeljanz to treat ulcerative colitis pharmaceutical-technology
July 18, 2017
The US Food and Drug Administration (FDA) has accepted for filing Pfizer’s supplemental New Drug Application (sNDA) for Xeljanz (tofacitinib citrate), an investigational oral solution to treat adult patients affected with moderately to severely active ulc

Previous page 1 2 3 4 5 6 7 8 9 10 ... 83 84 Next page